Addus HomeCare (NASDAQ:ADUS - Get Free Report) was downgraded by investment analysts at StockNews.com from a "buy" rating to a "hold" rating in a research note issued on Thursday.
ADUS has been the topic of several other reports. Stephens increased their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an "overweight" rating in a research report on Wednesday, November 6th. Royal Bank of Canada reiterated an "outperform" rating and set a $136.00 price target on shares of Addus HomeCare in a report on Thursday, November 14th. KeyCorp assumed coverage on shares of Addus HomeCare in a report on Friday, October 11th. They issued an "overweight" rating and a $150.00 price objective for the company. JMP Securities initiated coverage on Addus HomeCare in a research note on Monday, December 16th. They set an "outperform" rating and a $150.00 target price on the stock. Finally, Macquarie reaffirmed an "outperform" rating and set a $139.00 price target on shares of Addus HomeCare in a report on Monday, November 4th. One analyst has rated the stock with a sell rating, one has issued a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $133.67.
Get Our Latest Report on Addus HomeCare
Addus HomeCare Stock Up 1.6 %
Shares of ADUS stock traded up $2.05 during trading hours on Thursday, hitting $133.32. 121,651 shares of the company's stock traded hands, compared to its average volume of 128,775. The stock's fifty day simple moving average is $125.15 and its two-hundred day simple moving average is $126.34. Addus HomeCare has a 12-month low of $85.94 and a 12-month high of $136.12. The stock has a market cap of $2.42 billion, a price-to-earnings ratio of 30.51, a PEG ratio of 1.63 and a beta of 1.00.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business had revenue of $289.80 million during the quarter, compared to analysts' expectations of $289.42 million. During the same quarter in the previous year, the business earned $1.03 earnings per share. The firm's quarterly revenue was up 7.1% compared to the same quarter last year. On average, equities analysts forecast that Addus HomeCare will post 4.58 earnings per share for the current fiscal year.
Insider Buying and Selling at Addus HomeCare
In related news, CEO R Dirk Allison sold 25,000 shares of Addus HomeCare stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the transaction, the chief executive officer now directly owns 79,397 shares in the company, valued at approximately $9,905,569.72. The trade was a 23.95 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Roberton James Stevenson sold 2,250 shares of the business's stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the sale, the executive vice president now directly owns 10,217 shares of the company's stock, valued at $1,236,257. This represents a 18.05 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 39,750 shares of company stock worth $4,930,750 in the last three months. 4.60% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
Hedge funds have recently made changes to their positions in the stock. Point72 Asset Management L.P. lifted its holdings in Addus HomeCare by 73.4% during the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company's stock valued at $86,598,000 after purchasing an additional 315,602 shares in the last quarter. Millennium Management LLC raised its position in shares of Addus HomeCare by 412.7% during the 2nd quarter. Millennium Management LLC now owns 316,418 shares of the company's stock valued at $36,739,000 after purchasing an additional 254,705 shares during the period. Wasatch Advisors LP lifted its stake in shares of Addus HomeCare by 11.8% during the 3rd quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company's stock valued at $138,782,000 after buying an additional 110,010 shares in the last quarter. Ghisallo Capital Management LLC bought a new position in Addus HomeCare in the 2nd quarter worth $11,611,000. Finally, Principal Financial Group Inc. boosted its holdings in Addus HomeCare by 17.5% in the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company's stock worth $67,293,000 after buying an additional 75,409 shares during the period. 95.35% of the stock is currently owned by institutional investors.
Addus HomeCare Company Profile
(
Get Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.